Status:
COMPLETED
Association of C-reactive Protein-albumin-lymphocyte Index (CALLY) With All-cause Mortality in Diabetic Patients
Lead Sponsor:
Kunming Children's Hospital
Conditions:
Diabetes
Eligibility:
All Genders
40+ years
Brief Summary
Based on retrospective cohort data from 3,988 diabetic patients in the NHANES database, this study is the first to show a significant negative correlation between the CALLY index and all-cause mortali...
Detailed Description
All analyses accounted for NHANES sample weights, clustering, and stratification. We used EmpowerStats (v4.1, www.empowerstats.com) and R software (v4.4.1, www.r-project.org). Continuous variables wer...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- (1) self-reported doctor-diagnosed diabetes; (2) fasting blood glucose ≥ 7.0 mmol/L; (3) two-hour oral glucose tolerance test blood glucose ≥ 11.1 mmol/L; (4) glycated hemoglobin A1c (HbA1c) ≥ 6.5%; or (5) use of hypoglycemic medication.
Exclusion
Key Trial Info
Start Date :
April 8 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 8 2025
Estimated Enrollment :
3988 Patients enrolled
Trial Details
Trial ID
NCT06976359
Start Date
April 8 2025
End Date
May 8 2025
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kunming Children's Hospital
Kunming, Yunnan, China, 650000